Neurotologist John Carey specializes in the health and diseases of the inner ear that affect both balance and hearing mechanisms. He is a national expert in superior canal dehiscence syndrome, Menière’s disease, vestibular migraine, acoustic neuromas and other causes of vertigo, and serves as chief of the Division of Otology, Neurotology and Skull Base Surgery in the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Carey earned a medical degree from Washington University School of Medicine and completed two years of training in general surgery at Virginia Mason Medical Center. This was followed by residency training in otolaryngology–head and neck surgery at University of Washington Medical Center and fellowship training in neurotology at the Johns Hopkins University School of Medicine. His research interests include superior canal dehiscence syndrome, Menière’s disease, vestibular implants, and the mechanisms of vestibular migraine. He has a particular interest in superior canal dehiscence syndrome, and, with Lloyd Minor, department director from 2003 to 2009, he helped develop the operation used to repair the superior canal. Dr. Carey has been funded by the National Institute on Deafness and Other Communication Disorders, part of the National Institutes of Health. He has authored or co-authored over 150 peer-reviewed publications, 10 book chapters, and 11 reviews. Dr. Carey is rated as an Elite provider by MediFind in the treatment of Vertigo. His top areas of expertise are Meniere Disease, Vertigo, Acoustic Neuroma, Mastoidectomy, and Endoscopy.

With fellowship training in neuro-ophthalmology and additional training in neuro-vestibular disorders, Dr. Daniel Gold sees patients with neuro-ophthalmic disorders (affecting vision, eyelids, pupils, or causing nystagmus or double vision) in addition to oto-neurologic disorders (causing dizziness and vertigo). Videos 2018 Best Consulting Physician Award Tele-(Dizzy) Medicine. Dr. Gold is rated as an Elite provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Brown Syndrome, and Stiff Person Syndrome.

David Newman-Toker, M.D., Ph.D., is an internationally recognized leader in neuro-otology, acute stroke diagnosis, and diagnostic errors research. He completed his undergraduate studies at Yale University, his medical degree at University of Pennsylvania, his residency training and neuro-ophthalmology fellowship at Harvard University, his neuro-otology fellowship at Johns Hopkins University School of Medicine, and his doctoral degree in clinical research methods at the Johns Hopkins Bloomberg School of Public Health. He has served as a full-time faculty member at the Johns Hopkins University School of Medicine since 2002. He is the David Robinson Professor of Vestibular Neurology and also holds appointments in Otolaryngology, Ophthalmology, Emergency Medicine, Acute Care Nursing, Health Sciences Informatics, Epidemiology, and Health Policy & Management at Johns Hopkins. Dr. Newman-Toker is a bedside-to-populations translational researcher, with a focus on eliminating diagnostic errors and achieving diagnostic excellence. He is a leader in the national and international movements to eliminate patient harms from diagnostic error. Dr. Newman-Toker’s clinical focus is on diagnosis of acute disorders affecting the brainstem and cranial nerves, particularly stroke. He is recognized for his research in novel eye-movement-based bedside methods for diagnosing stroke in patients with acute dizziness and vertigo in the emergency department and, in 2024, won the international Bárány Society’s Hallpike-Nylén Prize for clinical research achievement. Dr. Newman-Toker serves as director of the Division of Neuro-Visual & Vestibular Disorders in the Department of Neurology. He also directs the Armstrong Institute Center for Diagnostic Excellence, whose mission is to catalyze efforts to improve diagnostic performance, develop the science of diagnostic safety, and enhance diagnostic research. He has been the principal investigator on numerous National Institutes of Health, Agency for Healthcare Research and Quality (AHRQ), and foundation grants. He has published over 165 journal articles and given more than 300 invited lectures. He has served as an expert consultant on diagnostic safety and quality to AHRQ, the National Quality Forum, and the National Academy of Medicine. He has testified before Congress on the use of artificial intelligence for medical diagnosis. He was president of the Society to Improve Diagnosis in Medicine from 2018-2020. Dr. Newman is rated as an Elite provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Benign Paroxysmal Positional Vertigo, Stroke, and Brown Syndrome.

David Zee is a Neurologist in Baltimore, Maryland. Dr. Zee is rated as an Elite provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Brown Syndrome, Cerebelloparenchymal Disorder 3, and Benign Paroxysmal Positional Vertigo. Dr. Zee is currently accepting new patients.

Charles C. Della Santina specializes in surgery for treatment of hearing, balance and other ear disorders including otosclerosis, cholesteatoma, conductive and sensorineural hearing loss, acoustic neuroma/vestibular schwannoma, glomus and other tumors of the temporal bone, and other problems that cause hearing loss or abnormal vestibular (inner ear balance) sensation. He is the director of the Johns Hopkins Cochlear Implant Center. He performs acoustic neuroma surgery, cochlear implantation, stapes surgery, middle ear bone reconstruction, bone-conduction hearing device implantation, other middle ear and mastoid surgeries, removal of glomus and other temporal bone tumors, surgical treatment of temporal bone cerebrospinal fluid leaks and encephaloceles, and surgery for vestibular disorders including superior canal dehiscence syndrome, Meniere’s disease, bilateral loss of vestibular sensation, gentamicin ototoxicity and other disorders. Dr. Della Santina earned a medical degree from the University of California San Francisco School of Medicine and a doctorate in biomedical engineering from the University of California, Berkeley College of Engineering. He completed residency training in otolaryngology at the Johns Hopkins University School of Medicine in 2002, and has served on the Johns Hopkins faculty since then. A biomedical engineer, electrical engineer and neurophysiologist, Dr. Della Santina founded and directs the Johns Hopkins Vestibular NeuroEngineering Lab. His research group focuses on developing a vestibular implant to treat chronic unsteadiness and oscillopsia (shaky vision during head movement) caused by gentamicin ototoxicity and other causes of bilateral vestibular hypofunction. His group’s world-leading research on vestibular implantation has been published in leading journals including the New England Journal of Medicine. Dr. Della Santina's more than 140 publications also include studies of inner ear physiology and anatomy, new clinical tests of vestibular function, and the effects of cochlear implantation, superior canal dehiscence syndrome and gentamicin on the inner ear. A biomedical engineer, electrical engineer and neurophysiologist, Dr. Della Santina founded and directs the Johns Hopkins Vestibular NeuroEngineering Lab. His research group focuses on developing a vestibular implant to treat chronic unsteadiness and oscillopsia (shaky vision during head movement) caused by gentamicin ototoxicity and other causes of bilateral vestibular hypofunction. Dr. Della Santina's more than 110 publications also include studies of inner ear physiology and anatomy; new clinical tests of vestibular function; and the effects of cochlear implantation, superior canal dehiscence syndrome, and gentamicin on the inner ear. Dr. Santina is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Jones Syndrome, Infant Hearing Loss, DFNB1, and Vertigo.

Nana Tevzadze is an Otolaryngologist in Baltimore, Maryland. Dr. Tevzadze is rated as an Advanced provider by MediFind in the treatment of Vertigo. Her top areas of expertise are Vertigo and Benign Paroxysmal Positional Vertigo.

Dr. Victor Urrutia serves as the medical director of the stroke service at The Johns Hopkins Hospital and director of the Sheikh Khalifa Stroke Institute. He focuses on the clinical aspects of cerebrovascular disease (stroke), specifically acute stroke therapy and prevention. Dr. Urrutia currently sees patients at the Stroke Prevention Clinic, located in the Johns Hopkins Outpatient Center in Baltimore on Wednesdays, and cares for patients in The Johns Hopkins Hospital's Brain Rescue Unit. Dr. Victor Urrutia received his medical degree from the University of Panama School of Medicine. He completed his neurology training at MCP Hahnemann University in Philadelphia, now Drexel University College of Medicine. After his residency training, he completed fellowship training in neurocritical care and acute stroke at Drexel University College of Medicine and became a faculty member in the neurocritical care and acute stroke division. He then returned to Panama for two years where he was the first to treat patients with IV thrombolytic therapy for acute stroke. Dr. Urrutia is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Stroke, Transient Ischemic Attack (TIA), Vertigo, Thrombectomy, and Gastrostomy.

Dr. Saber Tehrani is an Assistant Professor of Neurology at Johns Hopkins University School of Medicine. Dr. Saber Tehrani has unique subspecialty training in vascular neurology, neuro-ophthalmology, and vestibular neurology. He is available for consultation for patients with strokes affecting vision or balance. Research Summary Dr. Saber Tehrani’s research efforts are focused on posterior circulation stroke diagnosis and outcomes, and how such strokes can affect vision and balance. He is using novel ways to objectively measure abnormal eye movements indicative of stroke. Dr. Tehrani is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Vertigo, Stroke, Pica, Gastrostomy, and Stent Placement.

A leading expert on brain injury, Dr. Daniel F. Hanley has been a professor of neurology, neurosurgery, and anesthesiology/critical care medicine at the Johns Hopkins University School of Medicine since 1996 and was named the Jeffrey and Harriet Legum Chair of Acute Care Neurology. Dr. Hanley founded and directed the Johns Hopkins Neurocritical Care Unit, one of the first critical care units dedicated solely to neurosurgical and neurological patients. Subsequently, in 1999, he founded and continues to direct the BIOS Clinical Trials Coordinating Center (BIOS CTCC), formerly known as the Division of Brain Injury Outcomes. Under Dr. Hanley’s leadership, BIOS CTCC, an academic contract research organization based at Johns Hopkins, has organized and completed more than 20 large clinical trials. He has been awarded over 70 clinical and basic research grants, predominantly from the National Institutes of Health and the FDA Orphan Products Grants Program. Dr. Hanley’s 40-year career in medicine has focused on clinical trial design, the organization and interpretation of drug and device trials, the development of strategic research plans, and FDA regulatory compliance. He has led international, NIH-sponsored trials including the MISTIE III and CLEAR III trials investigating minimally invasive neurosurgical techniques to treat hemorrhagic stroke. As principal investigator for the National Center for Advancing Translational Sciences (NCATS) Johns Hopkins Trial Innovation Center, Dr. Hanley leads collaborative efforts to advance education and therapeutics through innovative CTSA clinical trials. Currently, Dr. Hanley is the PI or multi-PI for several ongoing trials. These include a multisite phase 2/3 randomized controlled dementia prevention trial (MAP), a large multicenter clinical trial involving automated monitoring of atrial fibrillation (REACT AF), and a first-in-patient phase 2a biomarker and edema attenuation in intracerebral hemorrhage trial (BEACH). Dr. Hanley has published over 400 peer-reviewed articles and book chapters, received the Humboldt Research Prize for accomplishments in brain injury research, and mentored nearly 100 researchers. His trainees, which include a large number of trialists, have led 25 brain intensive care units, and over 40 have been named full professors, program leaders, or department chairs. He has served on public boards including the American Academy of Neurology, National Stroke Association, and NIH National Institute of Nursing Research. Dr. Hanley is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Stroke, Hydrocephalus, Vertigo, Severe Acute Respiratory Syndrome (SARS), and Thrombectomy.

Dr. Julianna Czum’s primary focus is cardiothoracic imaging, with clinical subspecialties in noninvasive cardiovascular and thoracic imaging. Dr. Czum earned her medical degree from UMDNJ - Robert Wood Johnson Medical School before going on to an internship at Mary Imogene Bassett Hospital and residency at St. Barnabas Medical Center. She completed a fellowship in cardiovascular magnetic resonance in a combined Henry Jackson Foundation-funded program at the National Institutes of Health, National Naval Medical Center and Uniformed Services University of the Health Sciences. Dr. Czum joined the diagnostic faculty in June 2022. Dr. Czum is rated as an Advanced provider by MediFind in the treatment of Vertigo. Her top areas of expertise are Pleurisy, ALK-Positive Non-Small Cell Lung Cancer, Chronic Cough, and Lung Nodules.

Dr. John Eng is a Professor and Vice Chair of Faculty Academic Development in the Johns Hopkins Medicine Department of Radiology and Radiological Science with a joint appointment in the Division of Health Sciences Informatics at the Johns Hopkins School of Medicine. His area of clinical expertise is diagnostic radiology. Dr. Eng received his undergraduate degree from University of Wisconsin and earned his M.D. from University of Wisconsin Medical School. He completed his residency in radiology at Johns Hopkins Hospital. Dr. Eng was a Howard Hughes Medical Institute Research Scholar at the National Institutes of Health and a Robert Wood Johnson Clinical Scholar at Johns Hopkins. Dr. Eng’s research interests are in the statistical evaluation of diagnostic tests, radiology informatics, and evidence-based radiology. Dr. Eng is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Lung Nodules, Collapsed Lung, Pleural Effusion, and Pleurisy.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as an Advanced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Dr. Kheradmand is an Associate Professor of Neurology and Otolaryngology-Head and Neck Surgery, and specializes in vertigo, dizziness, imbalance, and disorders of eye movements. Dr. Kheradmand's research combines normal human neurophysiology and investigations in patients with disorders such as ocular misalignment, abnormal eye movements, nystagmus, and vestibular dysfunction. A special focus has been on understanding the mechanisms of spatial disorientation, and how their deleterious effects can be ameliorated. This work is translational, with an iterative process between the clinic and the laboratory with the goal of developing more accurate clinical diagnosis and better modes of treatment. Videos Vestibular Neuritis - Angela's Story Recent News Articles and Media Coverage He Got Dizzy and Sick When He Turned His Head. Why? New York Times (Nov. 7, 2025). Dr. Kheradmand is rated as an Experienced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Hereditary Ataxia and Vertigo.

Neurotologist Bryan Ward specializes in treating disorders of the ear and skull base, such as chronic ear disease, obstructive and patulous eustachian tube dysfunction, and conditions that cause dizziness, such as superior canal dehiscence syndrome, Meniere’s disease and bilateral vestibulopathy. Dr. Ward earned his medical degree from the University of Pittsburgh School of Medicine. He completed residency training in otolaryngology at the Johns Hopkins University School of Medicine, followed by fellowship training in eustachian tube disorders at Boston Children’s Hospital. He returned to Johns Hopkins for additional fellowship training in otology and neurotology. He has research interests in vestibular physiology and pathophysiology, with a particular focus on magnetic resonance imaging (MRI) and interactions between strong magnetic fields and the inner ear. The magnetic fields of MRI machines can induce a force in the inner ear that may cause dizziness and vertigo. This is a fundamentally new way of stimulating the vestibular system, and he is studying how the brain adapts to this stimulus. Dr. Ward is interested in understanding novel disorders of the inner ear vestibular system by developing improved MRI and via temporal bone histopathology. His clinical research interests include eustachian tube disorders, the pathophysiology of inner ear disorders such as superior semicircular canal dehiscence syndrome, Meniere’s disease and bilateral vestibulopathy, as well as novel treatments, including the development of a vestibular implant (led by Charles Della Santina). Dr. Ward is rated as an Experienced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Patulous Eustachian Tube, Acoustic Neuroma, Schwannoma, and Mondini Dysplasia.

Zahra Sayyid is an Otolaryngologist in Baltimore, Maryland. Dr. Sayyid is rated as an Experienced provider by MediFind in the treatment of Vertigo. Her top areas of expertise are Schwannoma, Acoustic Neuroma, Tinnitus, Patulous Eustachian Tube, and Laryngectomy.

Dr. Nieman is an associate professor in the division of otology, neurotology and skull base surgery in the Johns Hopkins Department of Otolaryngology-Head and Neck Surgery. Her clinical practice is dedicated to the medical and surgical management of hearing loss and Eustachian tube disorders. Dr. Nieman's research is directed at understanding and addressing hearing health disparities among older adults, particularly among vulnerable populations. Her work focuses on the development and implementation of innovative, community-delivered approached to affordable, accessible hearing care. Dr. Nieman is rated as an Experienced provider by MediFind in the treatment of Vertigo. Her top areas of expertise are Hearing Loss, Infant Hearing Loss, Jones Syndrome, DFNB1, and Myringotomy.

Lee Akst, M.D., specializes in treating the larynx (voicebox), in particular the treatment of voice and swallowing disorders. He is a leading laryngologist in office-based procedures such as vocal fold injection augmentation, pulsed KTP laser treatment, and laryngeal botox injection. In the operating room, Dr. Akst specializes in phonosurgery for the treatment of vocal cord disease, with emphasis on voice restoration and improvement. A strong focus of his practice involves the use of pulsed angiolytic lasers, which allow for subspecialized care of laryngeal papillomas, laryngeal dysplasia, and early vocal cord cancers while preserving the quality and strength of the voice. Dr. Akst is a national leader in the field of laryngology and serves in leadership roles for the American Laryngological Association, the American Broncho-Esophagological Association, and the American Academy of Otolaryngology-Head and Neck Surgery. He lectures extensively on the treatment of laryngeal disease, teaching other physicians how to care for patients with voice and swallowing concerns. His research interests include the development of robotic laryngeal surgery, the study of voice and swallowing complaints in the elderly, and the advancement of pulsed lasers for the treatment of laryngeal diseases with a focus on leukoplakia. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Akst is rated as an Experienced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Spasmodic Dysphonia, Laryngitis, Perichondritis, Endoscopy, and Laryngectomy.

Laryngologist Simon Best specializes in voice and airway disorders, including the comprehensive care of professional voice-users and performers. He treats patients diagnosed with recurrent respiratory papillomatosis (RRP), vocal cord paralysis, laryngeal cancer, precancerous vocal cord dysplasia, benign laryngeal lesions (polyps, cysts, nodules), and laryngeal and tracheal stenosis. He has expertise in the operative management of vocal cord disorders, including Blue Light laser surgery and office-based management of vocal cord papilloma, dysplasia and vocal cord paralysis. Dr. Best earned a medical degree from the Yale School of Medicine and completed residency training in Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. He undertook fellowship training in laryngology at Massachusetts General Hospital. Dr. Best has a particular clinical and research interest in recurrent respiratory papillomatosis and sees patients from across the country for specialized care for this disorder. He offers operative and office-based laser for papilloma, utilizing the Blue Light laser, which allows for precise excision of papilloma while preserving underlying vocal function. Dr. Best is also a pioneer in the adjuvant use of bevacizumab for RRP, helping many patients break the cycle of repeated surgeries. The Best Laboratory studies RRP and the development of novel immunotherapies to target the underlying viral infection. This research is conducted in collaboration with the head and neck cancer and cervical cancer research groups at Johns Hopkins, which also study human papillomavirus-related diseases. In addition, Johns Hopkins is a site for ongoing clinical trials in DNA immunotherapy, the goal of which is to eliminate the causative viral infection that leads to RRP. Dr. Best is rated as an Experienced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Laryngeal Nerve Damage, Recurrent Respiratory Papillomatosis, Spasmodic Dysphonia, Laryngectomy, and Gastrostomy.

Dr. Bimal H. Ashar is a Professor of Clinical Medicine at the Johns Hopkins University School of Medicine. He serves as the Interim Director of the Division of General Internal Medicine, Clinical Director of the Division of General Internal Medicine, and Director of the Executive & Preventive Health Program. Named one of the “Best Doctors in America”, Dr. Ashar’s primary research interests include preventive medicine, dietary supplements and medical education, and he has authored numerous book chapters and articles on these topics. Dr. Ashar is also an editor of The Johns Hopkins Internal Medicine Board Review book and a former consulting editor for the Medical Clinics of North America. Dr. Ashar is an active member of the Society of General Internal Medicine and has served as president for the mid-Atlantic region. He is also a fellow of the American College of Physicians. He obtained his medical degree from the University of Maryland School of Medicine. He completed his residency in internal medicine at Case Western Reserve University/University Hospitals of Cleveland. He subsequently became chief resident and a faculty member at Case Western. Dr. Ashar left Cleveland in 1998 and joined the faculty in the Division of General Internal Medicine at Johns Hopkins University. This provider is registered with the Florida Department of Health to perform telehealth services for patients in Florida and has active medical licenses in Maryland and Washington, D.C.. Videos 2017 Excellence in Service and Professionalism Award - Bimal Ashar, M.D., The Johns Hopkins Hospital Recent News Articles and Media Coverage Young MDs Hazy on Dietary Supplements, Wall Street Journal, May 14, 2007. Dr. Ashar is rated as an Experienced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Mevalonate Kinase Deficiency, Hypertension, Brugada Syndrome, and Short QT Syndrome.

Alexander Hillel specializes in the medical and surgical management of patients who have scar tissue blocking their larynx and/or trachea, a condition called laryngotracheal stenosis. This condition occurs in patients who have had prolonged intubation, an autoimmune disease or a rare disease called idiopathic subglottic stenosis. He also treats patients with voice and throat problems, including spasmodic dysphonia and swallowing difficulty. After he earned his medical degree from the Tulane University School of Medicine, Dr. Hillel completed his residency in otolaryngology–head and neck surgery at the Johns Hopkins University School of Medicine and a fellowship in laryngology and airway surgery at the Emory Voice Center. Dr. Hillel directs a laboratory that seeks to better understand why scar forms in the larynx and trachea. In an effort to improve treatment, he and his team investigate the relationship between the immune system, bacteria and other antigens and scar formation in the airway. He has led a number of clinical trials to improve treatment for subglottic stenosis, including the first interventional study for idiopathic subglottic stenosis. Researchers in Dr. Hillel’s lab are also testing drugs that may halt the progression of, or reverse, scar formation, and they have engineered a drug-eluting stent that is being tested to translate to patients with subglottic stenosis. He holds sponsored grants to conduct his research from the National Institutes of Health, surgical foundations and the medical device industry. In addition to clinical and research work, Dr. Hillel has a leadership role within the Department of Otolaryngology–Head and Neck Surgery, serving as the vice director of education. Dr. Hillel is rated as an Experienced provider by MediFind in the treatment of Vertigo. His top areas of expertise are Spasmodic Dysphonia, Subglottic Stenosis, Perichondritis, Laryngectomy, and Endoscopy.